Plasma Ltbp2 levels predict all-cause mortality, particularly pulmonary death, in patients with acute dyspnoea (including patients with chronic obstructive pulmonary disease and pneumonia acute pulmonary embolism) (Breidthardt et al., 2012). The gene discussed is LTBP2; the disease is susceptibility to pneumonia measurement.